- London
- Hybrid · 2 days in office
- US$242,250 – US$403,750 pa
- Director · manages people
Accountable for end-to-end clinical development strategy for a multi-tumor oncology asset, spanning first-in-human through registrational trials, regulatory filing and initial market launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams across research, precision medicine, medical affairs and commercial. Requires deep antibody-drug conjugate and global health authority experience.